PIGN-Congenital Disorder of Glycosylation

Sponsored diagnostic testing programs for PIGN-Congenital Disorder of Glycosylation

PIGN-CDG is a congenital GPI-anchor biosynthesis disorder presenting with developmental delay, hypotonia, epilepsy, and multiple congenital anomalies such as facial dysmorphism or organ malformations. Severity is often high with significant neurologic involvement. Genetic testing confirms the diagnosis and guides management and recurrence risk counseling.

1 program found for PIGN-Congenital Disorder of Glycosylation

Programs

1 program
Invitae Unlock™

Invitae Epilepsy Panel

This program provides access to genetic testing for pediatric patients under 18 who present with an unprovoked seizure. The panel evaluates key epilepsy-associated genes to support diagnostic confirmation, inform prognosis, and guide clinical management. Testing is available to eligible patients when ordered by a licensed healthcare provider.

Neurology